Biolase, Inc. (BIOL) CEO Todd Norbe on Q3 2018 Results - Earnings Call Transcript [Seeking Alpha]
Biolase, Inc. (BIOL)
Last biolase, inc. earnings: 3/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
biolase.com/investors
Company Research
Source: Seeking Alpha
Biolase, Inc. (NASDAQ: BIOL ) Q3 2018 Earnings Conference Call November 13, 2018 10:30 AM ET Executives Michael Polyviou - EVC Group LLC Todd Norbe - President and Chief Executive Officer John Beaver - EVP and Chief Financial Officer Analysts Lisa Springer - Singular Research, LLC Yi Chen - H.C. Wainwright Paul Bornstein - Black Diamond Ed Woo - Ascendiant Capital Operator Good morning ladies and gentlemen, and welcome to the Third Quarter 2018 BIOLASE Earnings Conference Call. As a reminder, this conference call is being recorded. I would now like to introduce your host for today’s conference Michael Polyviou of EVC Group. You may begin, sir. Michael Polyviou Thank you, Rob. Good afternoon, everyone, and thank you for joining us today to discuss BIOLASE's financial results for the 2018 third quarter and first nine months ended September 30, 2018. On the call today from BIOLASE are Todd Norbe, President and Chief Executive Officer; and John Beave
Show less
Read more
Impact Snapshot
Event Time:
BIOL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIOL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIOL alerts
High impacting Biolase, Inc. news events
Weekly update
A roundup of the hottest topics
BIOL
News
- BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
BIOL
Sec Filings
- 4/23/24 - Form 424B4
- 4/23/24 - Form EFFECT
- 4/19/24 - Form POS
- BIOL's page on the SEC website